✦ LIBER ✦

Sorafenib in renal cell carcinoma

✍ Scribed by José Ángel Arranz; Miguel Ángel Climent; José Luis González-Larriba; Luis León; José Pablo Maroto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

GSK-3 inhibition in vitro and in vivo en

✍ Hisashi Kawazoe; Vladimir N. Bilim; Andrey V. Ugolkov; Kaori Yuuki; Sei Naito; A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 739 KB

Inhibition of angiogenic and non-angioge

✍ Yuen, J S P; Sim, M Y; Siml, H G; Chong, T W; Lau, W K O; Cheng, C W S; Huynh, H 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 628 KB

SORAFENIB RECHALENGE IN METASTATIC RENAL

✍ Camillo Porta; Chiara Paglino; Ilaria Imarisio 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Re: Sorafenib in Advanced Clear-Cell Ren

✍ Pierre I. Karakiewicz; Georg Hutterer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Nutlin-3 enhances sorafenib efficacy in

✍ Rit Vatsyayan; Jyotsana Singhal; Lokesh Dalasanur Nagaprashantha; Sanjay Awasthi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Sorafenib rechallenge in patients with m

✍ Masahiro Nozawa; Yutaka Yamamoto; Takafumi Minami; Nobutaka Shimizu; Yuji Hatana 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB